There was also a statistically significant improvement over placebo with the rasagiline 0.5 mg group, yet the magnitude of improvement was lower.
6 Samuti esines statistiliselt oluline paranemine võrreldes platseeboga 0, 5 mg rasagiliini rühmas, kuid selle ulatus oli väiksem.